Liver failure in children with hepatitis A

Hepatology

Volumn 26, Issue 4, 1997, Pages 1018-1022

  Debray, Dominique ^a   Cullufi, Pascual ^a   Devictor, Denis ^a   Fabre, Monique ^a   Bernard, Olivier ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME;

EID: 0030880840     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260433     Document Type: Article

References (18)

1. Stuart JM, Majeed FA, Cartwright KAV, Room R, Parry JV, Perry KR, Begg NT. Salivary antibody testing in a school outbreak of hepatitis A. Epidemiol Infect 1992;109:161-166.
2. Hoofnagle JH, Carithers RL, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. HEPATOLOGY 1995;21:240-252.
3. Devictor D, Desplanques L, Debray D, Ozie Y, Dubousset AM, Valayer J, Houssin D, et al. Emergency liver transplantation for fulminant liver failure in infants and children. HEPATOLOGY 1992;16:1156-1162.
4. Devictor D, Debray D, Gauthier F, Soubrane O. Intensive care and immunosuppression after liver transplantation in children [Abstract]. Pediatr Nephrol 1996;10:C47.
5. Masada CT, Shaw BW, Zetterman RK, Kaufman SS, Markin RS. Fulminant hepatic failure with massive necrosis as result of hepatitis A infection. J Clin Gastrenterol 1993;17:158-162.
6. Zacarias J, Brinck P, Cordero J, Velasco M. Etiologies of fulminant hepatitis in pediatric patients in Santiago, Chile. Pediatr Infect Dis J 1987;6:686-687.
7. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in Liver Disease. New York: Grune & Stratton, 1970:282-298.
8. Sinclair SB, Greig PD, Blendis LM, Abecassis M, Roberts EA, Phillips MJ, Cameron R, et al. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E: a preliminary report. J Clin Invest 1989;84:1063-1069.
9. Bismuth CE, Houssin D. Reduced-sized orthotopic liver graft in hepatic transplantation in children. Surgery 1984;95:367-370.
10. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273-275.
11. Dubois F, Thevenas C, Caces E, Vol S, Doctoriarena A, Ecault JL, Goudeau A, et al. Séroépidémiologie de l'hépatite A dans six départements du Centre-Ouest de la France en 1991. Gastroenterol Clin Biol 1992;16:674-679.
12. Gimson AES, White YS, Eddelston ALWF, Williams R. Clinical and prognostic differences in fulminant hepatitis type A, B and non A non B. Gut 1983;24:1194-1198.
13. O'Grady JG, Gimson AES, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988;94:1186-1192.
14. O'Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97: 439-445.
15. O'Grady J. Management of acute and fulminant hepatitis A. Vaccine 1992;10(Suppl 1):S21-S23.
16. Bernuau J, Samuel D, Durand F, Saliba F, Bourliere M, Adam R, Gugenheim J, et al. Criteria for emergency liver transplantation in patients with acute viral hepatitis and Factor V below 50% of normal: a prospective study [Abstract]. HEPATOLOGY 1991;14:49A.
17. Donaldson WB, Gopinath R, Wanless IR, Phillips MJ, Cameron R, Roberts EA, Greig PD, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. HEPATOLOGY 1993;18:1370-1374.
18. Hollinger FB, Eickhoff T, Gershon A, Jong EC, Koff RS. Discussion: who should receive hepatitis A vaccine? A strategy for controlling hepatitis A in the United States. J Infect Dis 1995;171(Suppl 1):S73-S77.